A complaint filed in federal court last week "alleges Medtronic Inc. illegally marketed a relatively obscure medical device called a biliary stent in ways not approved by federal regulators," The (Minneapolis-St. Paul) Star Tribune
reports. "The complaint was filed in U.S. District Court in Boston by two former employees who claim they were harassed and then fired by the Fridley-based medical technology giant when they complained to their managers that so-called 'off-label' use of the stent could be harmful to patients." The whistleblowers allege that Medtronic "pressured and incentivized" its salespeople to push the device's use to treat vascular conditions instead of for their approved use related to tumors in several organs (Moore, 2/24).
This is part of Kaiser Health News' Daily Report - a summary of health policy coverage from major news organizations. The full summary of the day's news can be found here and you can sign up for e-mail subscriptions to the Daily Report here. In addition, our staff of reporters and correspondents file original stories each day, which you can find on our home page.